CStone Pharmaceuticals's total assets for Q2 2025 were ¥1.19B, a decrease of -14.46% from the previous quarter. HK:2616 total liabilities were ¥876.86M for the fiscal quarter, a -14.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.